• 270 days Could Crypto Overtake Traditional Investment?
  • 275 days Americans Still Quitting Jobs At Record Pace
  • 277 days FinTech Startups Tapping VC Money for ‘Immigrant Banking’
  • 280 days Is The Dollar Too Strong?
  • 280 days Big Tech Disappoints Investors on Earnings Calls
  • 281 days Fear And Celebration On Twitter as Musk Takes The Reins
  • 283 days China Is Quietly Trying To Distance Itself From Russia
  • 283 days Tech and Internet Giants’ Earnings In Focus After Netflix’s Stinker
  • 287 days Crypto Investors Won Big In 2021
  • 287 days The ‘Metaverse’ Economy Could be Worth $13 Trillion By 2030
  • 288 days Food Prices Are Skyrocketing As Putin’s War Persists
  • 290 days Pentagon Resignations Illustrate Our ‘Commercial’ Defense Dilemma
  • 291 days US Banks Shrug off Nearly $15 Billion In Russian Write-Offs
  • 294 days Cannabis Stocks in Holding Pattern Despite Positive Momentum
  • 295 days Is Musk A Bastion Of Free Speech Or Will His Absolutist Stance Backfire?
  • 295 days Two ETFs That Could Hedge Against Extreme Market Volatility
  • 297 days Are NFTs About To Take Over Gaming?
  • 298 days Europe’s Economy Is On The Brink As Putin’s War Escalates
  • 301 days What’s Causing Inflation In The United States?
  • 302 days Intel Joins Russian Exodus as Chip Shortage Digs In
  1. Home
  2. News
  3. Breaking News

FDA Turns Its Back On “The Fountain Of Youth”

Blood

Legend is that Keith Richards of Rolling Stones went regularly to Swiss medical clinics to get his blood replaced in a bid to beat his lifestyle. It was just a legend, and never proven. But fast forward a couple of decades and we have Baby Boomers looking in greater numbers for that “fountain of youth”.

They think they found it, but the Federal Drug Administration (FDA) says “no”.

What the FDA is saying “no” to is this: An increasing number of companies offering injections of blood from younger people to combat the signs of aging. Last week, the FDA issued a statement expressing concern that “some patients are being preyed upon by unscrupulous actors touting treatments of plasma from young donors as cures and remedies.”

“Such treatments have no proven clinical benefits for the uses for which these clinics are advertising them, and are potentially harmful,” the FDA said.

The agency also said that some companies are selling plasma transfusions as supposed "treatments" for conditions like normal aging, memory loss, dementia, Parkinson’s disease, multiple sclerosis…

Even though the statement didn't call out any companies by name, it was clearly targeting the best-known among these—California-based Ambrosia Medical, which since 2017, Ambrosia ‘anti-aging” treatment for $8,000 for one liter of blood and $12,000 for two Related: Is Bitcoin Heading For A Bull Run?

Following the FDA’s warning, Ambrosia’s on Tuesday changed its website to state that it had “ceased patient treatments”.  

While the company says that most participants “see improvements” from the one-time infusion of a two-liter bagful of plasma, scientists and clinicians call it a scam.

But an opportunity is knocking hard on this vampire quest—and some won’t be able to resist.

Even the big dogs are toying with the idea. Google’s parent company, Alphabet, has invested heavily in its secretive anti-aging spinout, called Calico.

Celularity, a biotech giant Celgene spinoff, raised $250 million last year to try to use postpartum placentas to delay the aging process.

And then there is a company called Elysium Health, which has talked Nobel Prize winners into selling a $50-per-month supplement aimed at promoting longevity.

Related: Major Investment Banks Turn Bullish On Copper

Last year, one Florida-based former mortician and doctor announced the launch of a clinical trial giving participants blood infusions from young donors for $285,000 “enrollment” fee.

A couple of years ago, some U.S. citizens were reportedly hospitalized after traveling to Germany as “medical tourists” for a controversial treatment involving injections with sheep cells. They allegedly visited Germany twice a year for this type of treatment—involving fetal cells from sheep-which is not permitted in the U.S. The treatment is said to be used for everything from impotence to migraines, as well as anti-aging.

But from the FDA’s perspective, this is the 21st Centuries snake oil—and none of it has been proven.

By Michael Kern for Safehaven.com

More Top Reads From Safehaven.com:

Back to homepage

Leave a comment
  • Panskeptic on February 28 2019 said:
    You are flat-out wrong to lump Elysium Basis in with the other treatments. MIT is a respected scientific institution, and somehow I don't see a bunch of Nobel Prize-winners as gullible innocents.

    Go back and do some more research. This was just plain sloppy reporting.

Leave a comment